Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report 17 97K
2: EX-10.54(A) Material Contract 12 43K
3: EX-10.56 Material Contract 27 93K
4: EX-10.57 Material Contract 3 12K
5: EX-10.58 Material Contract 3 12K
6: EX-10.59 Material Contract 3 12K
7: EX-10.60 Material Contract 4 14K
8: EX-10.61 Material Contract 3 12K
9: EX-10.62 Material Contract 11 37K
10: EX-10.63 Material Contract 3 12K
11: EX-10.64 Material Contract 12 42K
12: EX-10.65 Material Contract 10 40K
13: EX-27 Financial Data Schedule (Pre-XBRL) 2 10K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
PHARMAGENICS, INC.
------------------------------
Exhibit 10.56
to
QUARTERLY REPORT ON FORM 10-Q
For Quarter Ended September 30, 1996
PHARMAGENICS, INC.
REGISTRATION RIGHTS AGREEMENT
This Agreement dated as of February 13, 1996 is entered into by and among
PharmaGenics, Inc., a Delaware corporation (the "Company"), the Existing
Investors listed on Schedule I hereto (the "Existing Investors") and the
purchasers of the shares (the "Shares") of Series C Convertible Preferred Stock,
$.01 par value (the "Series C Preferred Stock") of the Company listed on
Schedule II attached hereto (the "New Investors", and together with the Existing
Investors, the "Investors").
WHEREAS, the Existing Investors are holders of Series C Preferred
Stock of the Company (as defined herein);
WHEREAS, the New Investors desire to purchase the Shares pursuant to a
Subscription Agreement dated as of the date hereof (the "Subscription
Agreement"); and
WHEREAS, the Company, the Existing Investors and the New Investors
desire to set forth certain arrangements for the registration of the Restricted
Shares (as hereinafter defined) under the Securities Act of 1933, as amended, on
the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the mutual promises and covenants
contained in this Agreement, the parties hereto agree as follows:
1. CERTAIN DEFINITIONS. As used in this Agreement, the following
terms shall have the following respective meanings:
COMMISSION shall mean the U.S. Securities and Exchange
Commission, or any other federal agency at the time administering the Securities
Act.
COMMON STOCK shall mean the common stock, $0.01 par value per
share, of the Company.
EXCHANGE ACT shall mean the Securities Exchange Act of 1934, as
amended, or any similar federal statute, and the rules and regulations of the
Commission issued under the Exchange Act, as they each may, from time to time,
be in effect.
PREFERRED SHARES shall mean the Series C Preferred Shares held of
record by the Investors as of the Closing (as defined in the Subscription
Agreement).
PREFERRED STOCK shall mean the Series C preferred Stock.
PREFERRED STOCKHOLDERS shall mean, collectively, all holders of
Preferred Stock.
RESERVED SHARES shall mean the shares of Common Stock reserved by
the Company for issuance or actually issued upon conversion of the Preferred
Shares.
RESTRICTED SECURITIES shall mean the Preferred Shares or any of
the Reserved Shares issued upon conversion of the Preferred Shares which have
not been sold (a) in connection with an effective registration statement filed
pursuant to the Securities Act or (b) pursuant to Rule 144 promulgated by the
Commission under the Securities Act at any time after the Company shall have
satisfied or become in compliance with subparagraph (c) (i) of said Rule 144.
RESTRICTED SHARES shall mean the shares of Common Stock
constituting Restricted Securities.
SECURITIES ACT shall mean the Securities Act of 1933, as amended,
or any similar federal statute, and the rules and regulations of the Commission
issued under such Act, as they each may, from time to time, be in effect.
SERIES C PREFERRED SHARES shall mean the 977,034 shares of Series
C Preferred Stock owned by the Existing Investors and the shares of Series C
Preferred Stock purchased by the New Investors pursuant to the Subscription
Agreement, as indicated next to each New Investor's name on Schedule II.
SERIES C PREFERRED STOCK shall mean the Series C Convertible
Preferred Stock, $0.01 par value, of the Company.
SUBSCRIPTION AGREEMENT shall have the meaning set forth in the
Introduction.
STOCKHOLDERS shall mean all holders of capital stock of the
Company.
2. REQUIRED REGISTRATION. If the Company shall be requested (i) by
holders of at least 50% of the outstanding Restricted Securities to effect the
registration under the Securities Act of Restricted Shares or (ii) after the
first registration pursuant to this Section 2, by one or more of the holders of
Restricted Securities to effect the registration under the Securities Act of
Restricted Shares having a proposed aggregate offering price equal to or greater
than $5,000,000, the Company shall promptly give written notice of such proposed
registration to all holders of Restricted Securities, and thereupon the Company
shall promptly use its best efforts to effect the registration under the
Securities Act of the Restricted Shares that the Company has been requested to
register
-2-
for disposition as described in the request of such holders of Restricted
Securities within 30 days after the giving of the written notice by the Company;
PROVIDED, HOWEVER, that the Company shall not be obligated to effect any
registration under the Securities Act except in accordance with the following
provisions and Section 4:
(a) Subject to Section 4, the Company shall not be obligated to file
and cause to become effective more than two (2) registration statements in which
Restricted Shares are registered under the Securities Act pursuant to this
Section 2, if all of the Restricted Shares offered under those two (2)
registration statements are sold hereunder upon the price and terms offered.
(b) Anything contained herein to the contrary notwithstanding, with
respect to each registration requested pursuant to this Section 2, the Company
may include in such registration any authorized but unissued shares of Common
Stock (or authorized treasury shares) for sale by the Company or any issued and
outstanding shares of Common Stock for sale by others; PROVIDED, HOWEVER, that
if the number of shares of Common Stock so included pursuant to this clause (b)
exceeds the number of Restricted Shares requested by the holders of Restricted
Shares requesting such registration, then such registration shall be deemed to
be a registration in accordance with and pursuant to Section 3; PROVIDED
FURTHER, HOWEVER, that the inclusion of such previously authorized but unissued
shares by the Company or issued and outstanding shares of Common Stock by others
in such registration shall not adversely affect, in the reasonable opinion of
the holders of Restricted Shares requesting such registration, their ability to
effectively market the entire number of Restricted Shares requested by them.
(c) Anything contained herein to the contrary notwithstanding, the
Company shall not be obligated to cause to become effective a registration
statement under the Securities Act pursuant to this Section 2 until a date no
later than 6 months from the effective date of a registration statement under
the Securities Act filed by the Company registering securities of the Company
in its initial public offering of securities.
3. PIGGYBACK REGISTRATION.
(a) Each time that the Company proposes for any reason to register
any of its securities under the Securities Act (other than pursuant to a
registration statement on Form S-4 or Form S-8 or similar or successor forms
(collectively, "Excluded Forms")), the Company shall promptly give written
notice of such proposed registration to all holders of Restricted Securities,
which shall offer such holders the right to request inclusion of any Restricted
Shares in the proposed registration.
-3-
(b) Each holder of Restricted Securities shall have 30 days from the
receipt of such notice to deliver to the Company a written request specifying
the number of Restricted Shares such holder intends to sell and the holder's
intended method of disposition.
(c) In the event that the proposed registration by the Company is, in
whole or in part, an underwritten public offering of securities of the Company,
and request under Section 3(b) may specify that the Restricted Shares be
included in the underwriting (i) on the same terms and conditions as the shares
of Common Stock, if any, otherwise being sold through underwriters under such
registration or (ii) on terms and conditions comparable to those normally
applicable to offerings of common stock in reasonably similar circumstances in
the event that no shares of Common Stock other than Restricted Shares are being
sold through underwriters under such registration.
(d) Upon receipt of a written request pursuant to Section 3(b), the
Company shall promptly use its best efforts to cause all such Restricted Shares
to be registered under the Securities Act, to the extent required to permit sale
or disposition as set forth in the written request.
(e) Notwithstanding the foregoing, if the managing underwriter
determines and advises in writing that the inclusion of all Restricted Shares
proposed to be included in the underwritten public offering, together with any
other issued and outstanding shares of Common Stock proposed to be included
therein by holders other than the holders of Restricted Securities (such other
shares, collectively, the "Other Shares"), would interfere with the successful
marketing of such securities, then the number of Restricted Shares and Other
Shares to be included in such underwritten public offering shall be reduced,
FIRST, (i) from the number of shares requested to be included in such
registration by the holders of Other Shares (on a PRO RATA basis based on the
number of shares requested to be included in such registration by each such
holder), and SECOND, if necessary, (ii)(A) one-half (1/2) of the remaining
number of shares to be reduced, from the shares proposed to be registered by the
Company, and (B) one-half (1/2) of the remaining number of shares to be reduced,
from the number of Restricted Shares then owned by such holder of such
Restricted Shares (on a PRO RATA basis based upon the number of Restricted
Shares requested to be registered, if any by such holder). In each case, those
shares of Common Stock which are excluded from the underwritten public offering
shall be withheld from the market by the holders thereof for a period, not to
exceed 180 days, which the managing underwriter reasonably determines as
necessary in order to effect the underwritten public offering.
-4-
(f) The rights granted under this Section 3 shall not apply to the
initial public offering of the Company's Common Stock at a price of at least
$7.50 per share (subject to appropriate adjustment for stock splits, stock
dividends, combinations and other similar recapitalizations affecting such
shares) resulting in gross proceeds to the Company of at least $10,000,000.
4. REGISTRATIONS ON FORM S-2 OR S-3. At such time as the Company
shall have qualified for the use of Form S-2 or S-3 (or any successor form
promulgated under the Securities Act), each holder of Restricted Securities
shall have the right to request in writing an unlimited number of registrations
on Form S-2 or S-3. Each such request by a holder shall: (a) specify the
number of Restricted Shares which the holder intends to sell or dispose of; (b)
state the intended method by which the holder intends to sell or dispose of such
Restricted Shares; and (c) request registration of Restricted Shares having a
proposed aggregate offering price of at least $500,000. Upon receipt of a
request pursuant to this Section 4, the Company shall use its best efforts to
effect such registration or registrations on Form S-2 or S-3; PROVIDED, HOWEVER,
that in no event shall the Company be obligated to file and cause to be
effective more than one (1) Form S-2 or S-3 registration statement in any six
(6) month period.
5. PREPARATION AND FILING. If and whenever the Company is under an
obligation pursuant to the provision of this Agreement to use its best efforts
to effect the registration of any Restricted Shares, the Company shall, as
expeditiously as practicable:
(a) prepare and file with the Commission a registration statement
with respect to such securities and use its best efforts to cause such
registration statement to become and remain effective in accordance with Section
5(b) hereof;
(b) prepare and file with the Commission such amendments and
supplements to such registration statement and the prospectus used as may be
necessary to keep such registration statement effective for at least nine months
and to comply with the provisions of the Securities Act with respect to the sale
or other disposition of all Restricted Shares covered by such registration
statement;
(c) furnish to each selling stockholder such number of copies of
any summary prospectus or other prospectus, including a preliminary prospectus,
in conformity with the requirements of the Securities Act, and such other
documents as such seller may reasonably request in order to facilitate the
public sale or other disposition of such Restricted Shares;
-5-
(d) use its best efforts to register or qualify the Restricted
Shares covered by such registration statement under the securities or blue sky
laws of such jurisdictions as each such seller shall reasonably request and do
any and all acts or things which may be necessary or advisable to enable such
seller to consummate the public sale or other disposition in such jurisdictions
of such Restricted Shares; PROVIDED, HOWEVER, that the Company shall not be
required to consent to general service of process for all purposes in any
jurisdiction where it is not then subject to process, qualify to do business as
a foreign corporation where it would not be otherwise required to qualify or
submit to liability for state or local taxes where it is not liable for such
taxes;
(e) notify each seller of Restricted Shares covered by such
registration statement, at any time when a prospectus relating thereto covered
by such registration statements is required to be delivered under the Securities
Act within the appropriate period mentioned in Section 5(b) hereof, of the
happening of any event as a result of which the prospectus included in such
registration, as then in effect, includes an untrue statement of a material fact
or omits to state a material fact required to be stated therein or necessary to
make the statements therein not misleading in light of the circumstances then
existing and, at the request of such seller, prepare and furnish to such seller
a reasonable number of copies of a supplement to or an amendment of such
prospectus as may be necessary so that, as thereafter delivered to the
purchasers of such shares, such prospectus shall not include an untrue statement
of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading in light of
the circumstances then existing; and
(f) furnish, at the request of any holder requesting
registration of Restricted Shares pursuant to this Agreement, on the date that
such Restricted Shares are delivered to the underwriters for sale in connection
with a registration pursuant to this Agreement, if such securities are being
sold through underwriters, or, if such securities are not being sold through
underwriters, on the date that the registration statement with respect to such
securities becomes effective, (i) an opinion, dated such date, of the counsel
representing the Company for the purposes of such registration, in form and
substance as is customarily given to underwriters in an underwritten public
offering, addressed to the underwriters, if any, and to the holder or holders
making such request, and (ii) a letter dated such date, from the independent
certified public accountants of the Company, in form and substance as is
customarily given by independent certified public accountants to underwriters in
an underwritten public offering, addressed to the underwriters, if any, and to
the holder or holders making such request.
-6-
6. EXPENSES. All expenses incurred by the Company in complying with
this Agreement, including, without limitation, all registration and filing fees
(including all expenses incident to filing with the National Association of
Securities Dealers, Inc.), fees and expenses of complying with securities and
blue sky laws, printing expenses and fees and disbursements of counsel,
including with respect to each registration effected pursuant to Section 2, the
reasonable fees and disbursements of not more than one counsel for the Investors
as selling stockholder(s) thereunder will be paid by the Company; PROVIDED,
HOWEVER, that all underwriting discounts and selling commissions applicable to
the Restricted Shares covered by registrations effected pursuant to Section 2,3
or 4 hereof shall be borne by the seller or sellers thereof, in proportion to
the number of Restricted Shares sold by such seller or sellers.
7. INDEMNIFICATION.
(a) In the event of any registration of any Restricted
Shares under the Securities Act pursuant to this Agreement or registration or
qualification of any Restricted Shares pursuant to Section 5(d) hereof, the
Company shall indemnify and hold harmless the seller of such shares, each
underwriter of such shares, if any, each broker or any other person acting on
behalf of such seller and each other person, if any, who controls any of the
foregoing persons, within the meaning of the Securities Act, against any losses,
claims, damages or liabilities, joint or several, to which any of the foregoing
persons may become subject under the Securities Act or otherwise, insofar as
such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon an untrue statement or alleged untrue statement
of a material fact contained in any registration statement under which such
Restricted Shares were registered under the Securities Act, any preliminary
prospectus or final prospectus contained therein, or any amendment or supplement
thereto, or any document incident to registration or qualification of any
Restricted Shares pursuant to Section 5(d) hereof, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading
or, with respect to any prospectus, necessary to make the statements therein in
light of the circumstances under which they were made, not misleading, or any
violation by the Company of the Securities Act or state securities or blue sky
laws applicable to the Company and relating to action or inaction required of
the Company in connection with such registration or qualification under such
state securities or blue sky laws. The Company shall reimburse such seller,
such underwriter, broker or other person acting on behalf of such seller and
each such controlling person for any legal or any other expenses reasonably
incurred by any of them in connection with investigating or defending any such
loss, claim,
-7-
damage, liability or action; PROVIDED, HOWEVER, the Company shall not be liable
in any such case to the extent that any such loss, claim, damage or liability
arises out of or is based upon an untrue statement or alleged untrue statement
or omission or alleged omission made in said registration statement, said
preliminary prospectus, said prospectus, or said amendment or supplement or any
document incident to registration or qualification of any Restricted Shares
pursuant to Section 5(d) hereof in reliance upon and in conformity with written
information furnished to the Company by such seller or such underwriter
specifically for use in the preparation thereof.
(b) Before Restricted Shares held by any prospective seller
shall be included in any registration pursuant to this Agreement, such
prospective seller and any underwriter acting on its behalf shall have agreed to
indemnify and hold harmless (in the same manner and to the same extent as set
forth in paragraph (a)) the Company, each director of the Company, each officer
of the Company who shall sign such registration statement and any person who
controls the Company within the meaning of the Securities Act, with respect to
any untrue statement or omission from such registration statement, any
preliminary prospectus or final prospectus contained therein, or any amendment
or supplement thereto, if such untrue statement or omission was made in reliance
upon and in conformity with written information furnished to the Company through
an instrument duly executed by such seller or such underwriter specifically for
use in the preparation of such registration statement, preliminary prospectus,
final prospectus or amendment or supplement; PROVIDED, HOWEVER, that the maximum
amount of liability in respect of such indemnification shall be limited, in the
case of each prospective seller, to an amount equal to the net proceeds actually
received by such prospective seller from the sale of Restricted Shares effected
pursuant to such registration.
(c) Promptly after receipt by an indemnified party of
notice of the commencement of any action involving a claim referred to in this
Section 7(a) or (b), such indemnified party will, if a claim in respect thereof
is made against an indemnifying party, give written notice to the latter of the
commencement of such action. In case any such action is brought against an
indemnified party, the indemnifying party will be entitled to participate in and
to assume the defense thereof, jointly with any other indemnifying party
similarly notified to the extent that it may wish, with counsel reasonably
satisfactory to such indemnified party, and, after notice from the indemnifying
party to such indemnified party of its election to assume the defense thereof,
the indemnifying party shall be responsible for any legal or other expenses
subsequently incurred by the latter in connection with the defense thereof;
PROVIDED, HOWEVER, that, if any indemnified party shall have reasonably
concluded that there may be one or more legal defenses available
-8-
to such indemnified party which are different from or additional to those
available to the indemnifying party, or that such claim or litigation involves
or could have an effect upon matters beyond the scope of the indemnity agreement
provided in this Section 7, the indemnifying party shall not have the right to
assume the defense of such action on behalf of such indemnified party, and such
indemnifying party shall reimburse such indemnified party and any person
controlling such indemnified party for that portion of the fees and expenses of
any counsel retained by the indemnified party which are reasonably related to
the matters covered by the indemnity agreement provided in this Section 7. The
indemnifying party shall not make any settlement of any claims indemnified
against hereunder without the written consent of the indemnified party or
parties, which consent shall not be unreasonably withheld.
(d) Notwithstanding any of the foregoing, if, in connection
with an underwritten public offering of the Common Stock, the Company, the
selling stockholders and the underwriters enter into an underwriting or purchase
agreement relating to such offering which contains provisions covering
indemnification among the parties, the indemnification provisions of this
Section 7 shall be deemed inoperative for purposes of such offering.
8. INFORMATION BY HOLDER. Each Stockholder including Restricted
Shares in any registration shall furnish to the Company such information
regarding such Stockholder and the distribution proposed by such Stockholder as
the Company may reasonably request in writing and as shall be required in
connection with any registration, qualification or compliance referred to in
this Agreement.
9. INVESTOR "STAND-OFF" AGREEMENT. Each Investor, if requested by
the Company and the managing underwriter of an offering by the Company of Common
Stock or other securities of the Company pursuant to a registration statement,
shall agree not to sell publicly or otherwise transfer or dispose of any
Restricted Shares or other securities of the Company held by such Stockholder
for a specified period of time not to exceed 30 days prior to, and 180 days
following, the effective date of such registration statement; PROVIDED, that:
(a) such agreement shall only apply to the first
registration statement covering Common Stock to be sold on its behalf to the
public in an underwritten offering; and
(b) all officers and directors of the Company enter into
similar agreements.
10. TRANSFERS OF RIGHTS. This Agreement, and the rights and
obligations of each Investor hereunder, may be assigned by such Investor to any
person or entity to which
-9-
Restricted Securities are transferred by such Investor, and such transferee
shall be deem an "Investor" for purposes of this Agreement; provided that the
transferee provides written notice of such assignment to the Company.
11. GENERAL.
(a) NOTICES. All notices, requests, consents, and other
communications under this Agreement shall be in writing and shall be delivered
(i) two business days after being sent by registered or certified mail, return
receipt requested, postage prepaid or (ii) one business day after being sent via
a reputable nationwide overnight courier service guaranteeing next business day
delivery, in each case to the intended recipient as set forth below:
If to the Company, at 4 Pearl Court, Allendale, New Jersey O7401,
Attention: President;
If to an Investor, at his or its address set forth in the Company's
stock ledger.
Any party may give any notice, request, consent or other communication
under this Agreement using any other means including, without limitation,
personal delivery, messenger services, telecopy, first class mail or electronic
mail), but no such notice, request, consent or other communication shall be
deemed to have been duly given unless and until it is actually received by the
party for whom it is intended. Any party may change the address to which
notices, requests, consents or other communications hereunder are to be
delivered by giving the other parties notice in the manner set forth in this
Section.
(b) ENTIRE AGREEMENT. This Agreement embodies the entire
agreement and understanding between the parties hereto with respect to the
subject matter hereof as it relates to the Restricted Securities and supersedes
all prior agreements and understandings relating to such subject matter as they
relate to the Restricted Securities.
(c) AMENDMENTS AND WAIVERS. Any term of this Agreement may
be amended and the observance of any term of this Agreement may be waived
(either generally or in a particular instance and either retroactively or
prospectively), with the written consent of the Company and the holders of at
least a majority of the Restricted Shares (including for this purpose Reserved
Shares issuable upon the conversion or exercise of Restricted Securities);
PROVIDED, that this Agreement may be amended with the consent of the holders of
less than all Restricted Shares only in a manner which affects all Restricted
Shares in the same fashion. No waivers of or exceptions to any term, condition
or provision of this Agreement, in any one or
-10-
more instances, shall be deemed to be, or construed as, a further or continuing
waiver of any such term, condition or provision.
(d) COUNTERPARTS. This Agreement may be executed in one or
more counterparts, each of which shall be deemed to be an original, but all of
which shall be one and the same document.
(e) SEVERABILITY. The invalidity or unenforecability of
any provision of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement.
(f) GOVERNING LAW. This Agreement shall be governed by and
construed in accordance with the internal laws of the State of New Jersey
(without reference to the conflicts of law provisions thereof).
-11-
[COUNTERPART SIGNATURE PAGE]
Executed as of the date first written above.
COMPANY:
PHARMAGENICS, INC.
By: /S/ MICHAEL I. SHERMAN, Ph.D.
--------------------------------------
Michael I. Sherman, Ph.D., President
NEW INVESTORS:
FOR ENTITIES:
ON FILE
----------------------------------------
[Insert Name of Purchaser]
By: /S/ ON FILE
--------------------------------------
Name:
Title:
FOR INDIVIDUALS:
By: /S/ ON FILE
--------------------------------------
Name:
EXISTING INVESTORS:
HEALTHCARE VENTURES III, L.P.
By: /S/ ON FILE
--------------------------------------
-12-
HEALTHCARE VENTURES IV, L.P.
By: /S/ ON FILE
--------------------------------------
EVEREST TRUST
By: /S/ ON FILE
--------------------------------------
PAINEWEBBER R&D PARTNERS III, L.P.
By: /S/ ON FILE
--------------------------------------
/S/ ON FILE
--------------------------------------
Larry Abrams
-13-
SCHEDULE I
EXISTING INVESTORS
Number of Shares of
Name Series C Preferred Stock
---- ------------------------
Healthcare Ventures III, L.P 247,202
Healthcare Ventures IV, L.P 72,593
Everest Trust 152,151
PaineWebber R&D Partners III, L.P. 480,242
Larry Abrams 24,846
-14-
SCHEDULE II
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
PaineWebber Inc., Custodian FBO Dr. M.B. Abaza IRA 10,000
Anthony M. & Allie J. Abbate 1,304
Carol A. Abdo 1,304
John E. Abdo Trust John E. Abdo TTEE 20,000
Larry Abrams 34,884
David H. Adamkin 10,000
Virgil J. Adams 652
Robert L. Aitchison 3,000
Robert Alati, George Laktzian, Gerald Jahn, Lawrence S. Stanko 1,304
Joseph B. Allegretti 5,200
PaineWebber Inc., FAO Alfonso Amato 652
Bruce B. Amshel 652
PaineWebber C/F Arthur Ancowitz IRA 1,304
C. John Anderson 1,300
Kurt Q. Anderson 5,000
Robert Anderson and Mary C. Anderson JT TEN 10,000
William C. Anderson 3,000
James C. Ruboyianes and Michael G. Anderson 652
I. Jackson Angell 652
Jack Argila and Joan Argila JT TEN 652
Stanley S. Arkin 2,608
B & G Tobacco & Candy Co., Inc. 15,000
Vincent Bacolini 1,304
Sharon Bahr 2,500
Betty Baker Trust 3,000
Phillip L. Baker Trust 3,000
Brad Baran and Barbara Baran JT TEN 1,304
Leonard Barrack & Lynne A. Barrack 1,304
John J. Genoa Jr. & Harry J. Barry 1,304
Ilene Barth 1,956
William L. Barton 2,500
Henry J. Basil 1,000
John R. Behrmann Revocable Trust 7,200
Doris Benson 1,000
Todd W. & Cinda R. Berman 2,000
Mildred C. Bianchi Living Trust DTD 11-14-84 652
H. Duane Billmeyer Jr. TTEE H. Duane Billmeyer Jr. TR UA DTD 3-13-81 2,000
Moye Lynwood Bishop, Jr. 652
William C. & Violette A. Blanks 2,800
Bertold Bodenheimer and Miriam Bodenheimer JT TEN 652
PaineWebber Inc. FAO Thomas H. Boehm & Renee R. Boehm 652
Warren F. Boos TTEE Warren F. Boos Revocable Trust DTD 2-27-91 1,956
-15-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
Bernard S. & Elaine M. Brandchaft Trust 8,000
Fred Harry Brandt 1,304
Jeffrey Bronson 652
Joseph B. & Carolyn O'Neil Bronushas 1,000
Barry D. Brooks, MD & Susan M. Creagan, MD 10,000
Olive Young Brown 1,304
Kenneth A. Brown TTEE Kenneth A. Brown Trust UAD 5/25/88 652
Courtney P. Brown Jr. 652
John J. Burke & Mary K. Burke 1,800
Leo J. Burke & Cindi Burke 652
James Burkoff 652
Beth Burnam Trust of 1993 Beth Burnam Trustee 13,044
Bruce Burnam Trust of 1992 Bruce Burnam Trustee 13,044
John R. Byerly 5,000
J. Richard Caldwell, Jr. & Jo Ann Caldwell 1,304
Patricia C. Carnes 1,000
Francis S. Carnes Jr. 1,000
Thomas R. Carney MD APC Profit Sharing Trust Fund DTD 6/25/74 652
Theodore R. Carski 1,400
Kenneth Carter & Karen G. Carter 3,000
A. Bailey Chapin 4,000
Chester Chastek 3,912
Iftikhar A. Chatha 652
Manu Chatterjee 12,608
M. Robert Ching & Phyllis Ching 1,304
Phyllis Ching 29,020
Victor Ching & Beverly Ching 1,304
Philip T. & Beverly Ching Revocable Living Trust DTD 6/28/88 1,304
Philip Ching MD Inc. Profit Sharing 1,304
Virginia L. Christy Revocable Trust 5,869
Perry Chu & Celia Chu 652
Priscilla K. Chu 652
CIRCLE C, L.P. Alfred A. Caro Trustee Alfred A. Caro Living Trust 7,600
James R. Clifton 652
Marguerite Collier 1,304
Roger Colton PA Profit Sharing Plan & Trust DTD 1/1/81 1,000
Lee Comer 5,000
Donald Ray & Delia E. Cook 8,800
Larry N. Cook and Christine L. Cook JT TEN 10,000
C. Gary Cooper MD Inc. Pension and Profit Sharing 652
Anthony Coppola IRA 1,304
Charles Costa 652
-16-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
Robert B. Costello & Marcia M. Costello 1,304
William A. Crosetto 4,000
Warren Cross 5,000
D. Jeanie Cushner & Charles Cushner 3,000
William Davidson 652
PaineWebber Inc. FAO Leslie A. Davis 652
Renee Crile Davis 1,000
Steven Dawes 652
Anthony Denisco 652
Alan S. Dernbach 1,304
PaineWebber CDN FBO Angela DiDomenico IRA 800
James R. Dobyns 652
Charles W.H. Dodge 652
Richard B. Donati & Donna J. Donati 2,804
PaineWebber C/F Gale Thomas Downey IRA 6,304
Joseph Dragoni 700
Thomas Dravis & Peggy Dravis 3,152
Grace R. Robbin or Vern Drehmel TTEES for the Drehmel-Robbin
Trust UA DTD 3/91 2,500
Paul Dresnick 652
Paul Dresnick Professional Corp Pension and Profit Sharing Plan 652
Scott F. Drill 8,000
Richard A. Dudek 1,200
Bennet Dworkis & Arlene Dworkis 800
Robert G. Easton 2,000
Nabil Ebraheim & Tracy Ebraheim 5,000
Charles C. Edwards 5,000
Electrolight Investments LTD 19,000
Palm Beach Ear, Nose, & Throat Assn. P.A. Profit Sharing Plan 2,608
William Epps RPT PA Employees Pension Plan 652
Thomas Nesgoda TTEE ER Doc Inc. Master Profit Sharing
Plan Trust DTD 1/89 17,500
Everest Trust 65,000
Frank E. Everett 20,200
William Farhet 1,304
R. Bruce Farmer 1,956
PaineWebber C/F R. Bruce Farmer IRA 5,652
James F. Fasi 2,500
Jerome J. Feder & Elayne J. Feder 2,500
Allen W. Feldman 2,500
Joseph & Carol C. Ferguson 15,000
Kenneth M. Fernandez 2,608
Donald J. Finnegan, Jr. 7,500
Sam N. Fisse 1,304
-17-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
Mickie Flanigan 7,600
Walter A. Forbes 652
George N. Forker, MD 4,000
John H. Forte 2,608
A. Steven Franchak 6,000
T.J. Franken & Julie L. Franken 10,000
Marvin Fribush & Dora Fribush 4,000
James Gaffney & Kathleen Gaffney 800
Subhash Gajendragadkar 1,304
John K. Garvey 15,200
Peter W. Gault and B. Christine Gault JT TEN 652
Carlson Gerdau 1,000
Alan S. Gertler & Doris L. Gertler 1,304
Fred Ghavidel 5,000
Fred Ghavidel and Kurt Anderson 2,608
Ruth Gilbert 1,000
PaineWebber Trust Co TTEE FBO John H. Gilmer Keogh 800
PaineWebber C/F David W. Gjerde IRA 2,000
Leonard M. Goldstein 652
James Gosman 2,500
C. Herbert Grauling, Jr. 2,600
Constance I. Graves 1,304
Robert M. Gray 652
John M. & Mary A. Grewe 978
Tom Gumprecht and Bonnie J. Witrak 6,000
George E. Hackney II and Eden H. Hackney JT TEN 1,000
Mark D. Hafermann & Vija Hafermann 1,304
William O. Hagerman 1,000
Jack D. Hagewood Profit Sharing Plan 1,304
Raymond A. Haik 1,000
PaineWebber C/F Robert J. Hall IRA 5,000
Robert G. Hamilton 3,000
Philip M. Hampton and Elaina F. Hampton JT TEN 7,600
Peter & Taffy Handy 1,304
James W. Harrington and Carole N. Harrington JT TEN 652
Brian F. Harris and Carolyn K. Harris Trustees
Harris Family Trust 10/20/88 10,000
Kenneth A. & Irene Hartung 1,500
Joseph W. Hasler 1,956
Robert C. Hawkins 5,000
HealthCare Ventures II, L.P. 232,558
David & Joan Heinke 652
Mark T. Hellner and Mary Lee Hellner JT TEN 652
-18-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
PaineWebber CDN FBO Glen A. Hemstock IRA 800
Howard C. Hines 1,304
Carl Hirsch and Anne D. Hirsch JT TEN 1,300
Leif Holgersen and Marcia Holgersen JT TEN 1,304
Joel Hollingshead & Judith Hollingshead JTWROS 1,304
Donald Horst 5,000
Nancy F. Howar 2,000
Victor Hsia and Virginia Hsia JT TEN 2,000
Henry T. Hsia & Alice Hsia Revocable Living Trust 1,304
Laura Huberfeld & Naomi Bodner A Partnership 140,000
Jane Ann Hudson-Davis 2,000
Charles E. Huffman and Jonita S. Huffman JT TEN 1,304
I.O. Co., Ltd. - A California Limited Partnership 20,000
Demarest Ingraham and Marion Ingraham JT TEN 652
Moreland R. Irby, Jr. 652
John Jacobs III 652
George D. Jagels, Jr. 10,000
William A. Janssen TTEE William A. Janssen Rev Trust 652
Theodore Johnson 24,800
Norman W. Johnston 2,500
David Jones & Sue Ann Jones 1,304
John Z. Jones and Arlene M. Jones JT TEN 652
Korey S. Jorgensen 652
Lanny M. Kalik & Gail Kalik 1,304
Venkateswara Kanubaddi 652
Daniel Kaplan 652
Leonard Karp and Cheryl L. Karp JT TEN 3,152
Daniel P. Kearney 1,304
Dimitri & Lorraine Kececioglu COTTEES Kececioglu Family
Trust DTD 6/30/89 2,325
Tom L. Kemph and Barbara Kemph 652
Mary L. Kenzie 652
Ross B. Kenzie 652
Gregory S. Pineda TTEE Kern Co. Neurological Med Group
Pension Plan UA 10-1-74 1,000
Gyanchand J. Khicha & Manorama G. Khicha TTEES
Gyanchand J. Khicha Liv Trust 4,800
Edwin A. Kilburn 4,000
Hyoung D. Kim 652
Rachel K. King 652
Robert W. King 2,500
Claudine B. Kirkwood 2,608
Sheldon W. Kirsner TTEE Sheldon W. Kirsner Rev Trust 10/14/87 1,304
Philip W. Klaus, Jr. 1,200
Ronald Kolker and Ruth Kolker JT TEN 2,000
-19-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
William Stanley Konetzki 4,600
Yvonne Koo 1,304
William E. Krauter 3,912
Janet M. Kroll 652
Jerome I. Kroll 652
Carl A. & Jacqueline Kuhn 1,304
Joyce A. Lagnese 2,804
J. Joseph Lally and Sharon F. Lally TTEES of the
Lally Living Trust DTD 6-8-92 23,500
Richard Landrum 652
Harold & Julie Lane 652
John Lane 600
Eivind G. Lange and Betty Ivey Lange TTEES FBO
Eivind & Betty Lange Living Trust 652
Ellen Larsen 1,304
Karl Larsen 1,304
Richard E. Lautner & James R. Nunn 1,000
Morgan A. Lawrence 8,600
Joohn Shik & Adrienne Ok-Ja Lee 10,000
Tennyson G. Lee and Esther K. Lee JT TEN 1,304
Robert Levy 5,000
Doree Levy 2,500
Nancy S. Lewis 2,000
Robert C. Lewis, Jr. 2,700
PaineWebber C/F Paul A. Lillejord IRA 652
Rong-Chung Lin and Shiow Bih Lin JT TEN 652
Bruce G. Livergood 1,304
Bruce G. Livergood IRA 652
Gail Livergood IRA 652
David A. Lombardero 2,000
Gary Z. Lotner and David G. Tinkelman TEN IN COM 652
Fredia Loveland 652
George A. Loveland 4,000
Thomas V. Loveland 652
Jack R. Loving 1,304
Frank J. Low and Edith M. Low JT TEN 652
David A. Lowry 2,000
Herbert Lucks and Anita H. Lucks JT TEN 3,260
PaineWebber C/F Kristi Lund Lozier IRA 5,000
Doris Lund Revocable Trust - Doris Lund TTEE 5,000
Lake Lytal, Jr. 1,304
Morton J. Macks 5,000
Brenda R. Majdalani 2,000
Bernard Manekin 4,000
-20-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
Harold Manekin 2,304
Wm. E. Manley 1,304
Rita N.A. Mansour 3,500
T. Joseph Mardelli, MD, PA Money Purchase & Pension
Trust DTD 11/1/86 FBO TJ Mardelli 1,304
PaineWebber Inc. FAO James A. Maritz III Trust 652
Cynthia Ann Maritz TTEE Cynthia Ann Maritz Trust 652
UMB Bank NA TTEE Toledo Radiological Assoc FBO Gerald Marsa 3,000
Dorothy Marshall 1,304
Patrick C. Massa and Patricia E. Massa JT TEN 1,304
Joseph & Carol McCormick 5,000
Michael F. McDermott 652
D.W. McDonald & Donna McDonald 1,304
Edwin P. McDuffie 652
Ralph L. McElroy 1,504
Harry McGowan 652
William B. McGuire 6,304
Rick & Deborah McKinney 21,304
James D. & Anne T. McLaughlin 2,800
John C. and Dorothy M. McNee Revocable Trust
John C. and Dorothy M. McNee TTEES 7,000
Edward T. McPhee, Jr. 5,000
J. Owen McPherson & Boatmen's First Nat'l Bank
TTEES of J. Owen McPherson Rev Trust 2,608
George F. Medill 5,000
Aristides Melissaratos 2,000
Robert G. Mennel, MD 1,000
W. Tom Meredith and Judith H. Meredith JT TEN 3,800
H. Kent Mergler 2,800
W.E. Michael Mikhail TTEE under Rev Trust of W.E.
Michael Mikhail DTD 7-19-95 20,000
Gary & Arlene Miller 652
Meredith Miller 1,652
Charles J. Miller III 800
Bonnie Minzer 652
Irwin Minzer 652
Richard E. Mistler Trustee Richard E. Mistler Trust 8,800
Kathleen Moody 5,652
Winship B. Moody, Sr. 652
Donald Morgan 652
Jon C. Moyle 652
Ferid & Carol A. Murad 3,913
PaineWebber C/F Kenneth Murdock IRA 2,500
Paul M. Murphy 3,800
Philippe G. Mutrux and Alice Marie Mutrux TTEES
Mutrux Rev Living Trust UTD 2-28-90 652
Edmund G. Nasief, Jr. and Nancy L. Nasief JT TEN 10,000
-21-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
James A. Nelson 5,000
James P. Newby 3,800
Samih F. Nimri 5,000
John S. Nolan 652
Walter J. Nott 4,652
The Oracle Fund Inc. 100,000
Steve A. Oravecz 3,000
Phyllis M. Oxtoby 2,400
Gwendolyn R. Paine 3,200
Ronald Pancner 652
Stelios Papadopoulos 50,000
Estate of Hilda B. Parker, Stephen L. Parker and
Marilou Parker Co-Executors 2,652
Donald R. & Margaret Mary Parks 10,200
Parkway Associates 652
Patheco Investment Partners, Ltd. Patrick Henry General Partner 1,304
Pathology Service Pension and Profit Sharing Trust FBO
Franklin H. Martin 7,500
Louis J. Patierno & Margaret S. Patierno 1,000
Charles H. Patterson & Sharon L. Patterson TTEES of
Patterson Family Trust DTD 2-2-84 1,304
Eugene Patton 3,000
Nan Pearlman 5,000
Nora R. Peek & Thomas R. Peek Co-TTEES U/A DTD 8/29/90
FBO Nora R. Peek Rev Trust 2,500
Xavier D. Pereira and Minda C. Pereira JT TEN 1,304
Clifford R. Perez & Janet R. Perez 652
Kenneth A. Perkins 2,608
Micheal C. Pistole, MD 1,304
Bernard E. Platt TTEE Bernard E. Platt Trust UAD 7-9-86 1,304
Donald Plochocki and Luanne Plochocki 1,304
Charles & Wendy Plotkin 7,600
John S. Poindexter III 652
Erich R. Pontasch, MD 4,100
Portico Investments Limited 6,522
John Potocki 1,000
William P. Potsic 1,304
J. Travis Prewitt 3,000
Donald H. Putnam, Jr. 6,000
David I. Rabo & Jean N. Rabo 652
Fred A. Rabo & Dorothy M. Rabo 652
Charles F. Radice and Alice Radice JT TEN 2,608
Robert C. Radice TTEE U/A DTD 8/7/91 for Robert C. Radice Trust 2,608
Noel P. Rahn 2,608
Ronald T. Ramge 1,200
Krishnamurti N. Rao TTEE Money Purchase Profit Sharing Plan DTD 8-1-86 1,304
-22-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
Hugh A. Raphael and Jo A. Raphael JT TEN 652
Jose Raquel 2,652
Mark B. Ratterman TTEE Mark B. Ratterman Rev Living Trust DTD 12-12-87 1,304
Mary G. Ray 1,956
V. Chandra Sekhar Reddy 1,304
William H. Reeder Trust William G. Reeder Trustee 1,304
Michael Reese and Pamela Reese JT TEN 2,608
Frederick N. Reidenbach 1,304
Mary G. Reinbolt 3,000
Philip T. Resha 1,304
Richard Ressner & Margaret Ressner 2,500
Madaiah Revana 1,304
Gerald David Ritland 3,002
Louis Rizzo and Grace Rizzo JT TEN 1,304
Leon Robbin 5,000
Gary & Joanne Robertson 652
Arthur J. Rose III 3,600
Julius A. Rosenthal Residuary Marital Trust UA DTD 3-25-88
Barry H. Rosenthal TTEE 2,608
Dennis L. Ross & Ann M. Ross 3,800
Tom Rossi 652
Dermot F. Rowland 1,304
Jean C. Rubin 3,000
Kevin A. Rubin 3,000
Joel William Rudd Living Trust 1,304
Craig A. Rush IRA 2,500
Laurence P. Russe Trust U/I/T 5/30/85 1,304
Peter J. Russo 5,000
Stephen R. Saddemi 3,000
Herbert D. Sahar & Lorraine M. Sahar 2,608
Nasr N. Salaita and Miriam B. Salaita JT TEN 652
Joseph S. Sanfilippo and Patricia M. Sanfilippo JT TEN 24,000
Costas Sarantopoulos 3,600
Sarcar Associates 652
Phillip G. Saunders 1,304
John & Virginia Schilling 652
David Schmitz 20,000
Gerald E. Schneider 1,304
Roger Schnell 3,912
Kenneth, Russell & William Schomig SUCC Co-TTEES U/A/D 8/1/89
Rita R. Schomig Trust 1,000
Charles N. Schumann & Helen Schumann 1,304
Kathleen F. Schwieger 800
Jean Rockwell Scudder 652
-23-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
Donald L. Sears 1,152
M.J. Seby & Ann Seby 652
Cabot Sedgwick 1,652
George A. Sedlock 652
Thomas J. Sedlock 2,800
Narendra N. Shah & Kamini N. Shah 652
Ratilal N. Shah & Bonny K. Shah 1,500
Gerald Joseph Shaughnessy IRA 2,000
Oliver Shaw TTEE Oliver Shaw Living Trust 9-12-91 2,608
Harvey L. Shephard & Dale Shephard TTEES for the Shephard Trust 2,608
Martin P. & Susan R. Sherman 3,488
Michael I. Sherman 12,000
Otto A. Silha 1,304
Dr. Jogendra & Kirpal Kaur Singh 2,304
Dean O. Smith 3,800
Robert G. & Linda V. Smith 7,000
Stewart W. Smith & Nancy W. Smith 2,652
Thomas J. Smith 3,000
Ronald E. Solomon 1,304
Sos & Co 6,522
Joe M. Sowder and Alice V. Sowder JT TEN 1,304
James R. Richman and Harold S. Spar JT TEN 1,304
Arnold Sperling & Lynn Sperling 15,000
Eileen Spigelmire 1,500
Robert H. Spitzer & Elizabeth A. Spitzer JT TEN 652
Arnold Stadheim 652
John Stafford 13,000
PaineWebber C/F Ernie Stautner Rollover IRA 1,300
Corey A. Steadman 2,600
John R. Stephens 10,000
Dominic Stevens & Mary Stevens 652
Daniel J. & Elvera Stock 2,977
Margaret E. Hancock, TTEE Stremark Trust U/A DTD 6-30-93 3,000
Michael D. Strum 652
Ellen Su 1,304
Marvin Sundquist 1,304
PaineWebber C/F Michael Swanson IRA 5,000
George Tallyn 2,652
Irene C. Tanury Trust DTD 1-19-85 1,000
S. James Tanury Trust 1,000
Swannie Zink Tarbel 1,500
John V. Thiemann Trust DTD 5-21-75 2,608
-24-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
Lawrence E. Thomas and Mary Ellen Thomas JT TEN 652
Lenerd G. Thomas Family Trust 2,600
John F. Thomas Trust 3,000
Elisa F. Thomases 1,800
PaineWebber C/F Pamela Morris Thomford IRA 2,500
Michael A. Thompson 2,000
Sioe Thung Thompson 4,000
Frank L. Thompson TTEE Thompson Living Trust 7,608
Severt W. Thurston, Jr. 1,304
James G. Tierney and Shirley A. Tierney TTEES FBO
The Tierney Family Trust 1,304
Gary D. Timm & Susan T. Timm 2,000
Gil Timm & Trili Timm 1,304
Michael L. Timm & Karen G. Timm 1,304
A. Thomas Traina 2,500
Tri - Lateral Trading Company 2,608
Gerald F. Tuohy & Darlene Tuohy 652
Louis Keimach & A. Raymond Tye 652
United Electric Co., Inc. 15,000
James E. Valentine 1,304
Fred C. Van Bebber 3,800
Claudio E. Vincenty and Kim M. Vincenty JT TEN 652
Richard L. Voorhees 3,000
Harvey Wallack MD Medical Corp Target Benefit Plan 5,304
Doris A. Walsh 3,000
John D. Warner 1,304
Jerry Watkins 652
Frank Weatherman & Glenna Weatherman JT TEN 652
PaineWebber C/F Marvin Weathers IRA 652
James A. Weaver 3,912
William J. Webber 3,000
Walter U. Weber & Marlene A. Weber 652
Martin L. Weich & Sharon G. Weich 5,652
Arnold Weiss 652
John E. Wenaas 3,652
Barbara Wertheimer 2,500
Frederick Wertheimer 5,000
Terry L. Whipple 652
Bruce Whitaker IRA 2,000
Charles S. White III, MD 10,000
Andrew Wiegand 3,000
Anders P. Wiklund 10,000
Michael M. Wild Trust U/A DTD 6-30-77 1,000
-25-
NEW INVESTORS
Number of
Shares of
Series C
Preferred
Name Stock
---- ---------
PaineWebber C/F Alfred C. Wilder IRA 1,304
Estate of H.J. Wilkens Minel Wilkens Executor 652
Peter P. Williams 652
Keith Wilson 1,304
Adrian Woldring and Connie Woldring 652
Wolowitz Partners Pension Fund 5,200
Bernice M. Woock Revocable Trust DTD 6-5-90 652
Tom R. Wootten & Miriam Wootten 652
Martin & Phyllis Yocum 652
Mark Zaharski & Donna Zaharski 1,000
Peter Zes & Joan Zes 652
PaineWebber C/F Ronald W. Zesch IRA 2,500
PaineWebber CDN FBO Donald C. Zickus IRA 800
Tom S. Ziems 3,000
-26-
Dates Referenced Herein and Documents Incorporated by Reference
| Referenced-On Page |
|---|
| This ‘10-Q’ Filing | | Date | | First | | Last | | | Other Filings |
|---|
| |  |
| | 11/14/96 |
| Filed on: | | 11/13/96 |
| For Period End: | | 9/30/96 | | 1 | | | | | 8-K |
| | 2/13/96 | | 2 |
| List all Filings |
↑Top
Filing Submission 0000912057-96-026140 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Thu., Apr. 25, 6:38:48.2am ET 